Autism Prevalence Is Rising, But the Conversation Needs More Nuance
Autism is one of the most important pediatric health conversations of our time.
Autism spectrum disorder is a complex neurodevelopmental condition that affects communication, social interaction, sensory processing, behavior, and cognitive development. While some autistic individuals live independently, others experience significant intellectual disability, medical complexity, or developmental challenges that require lifelong support.
According to the CDC’s Autism and Developmental Disabilities Monitoring Network, autism prevalence has continued to rise, with recent estimates identifying autism in approximately 1 in 31 children. As awareness and screening have improved, more children are being recognized earlier. But improved detection alone does not fully explain the clinical complexity many families are living with.
At Neuronutrition Associates, we believe families deserve a thoughtful, science-based conversation about autism that is neither dismissive nor fear-based.
Autism has also become one of the most important conversations in modern pediatrics, with families seeking answers that go beyond symptoms and explore the underlying biology that may contribute to a child’s presentation.
Autism is not caused by one single factor. Research suggests that genetic factors, gene variations, environmental influences, immune activation, and prenatal exposures may all contribute to autism risk. In some children, inherited genetic patterns or spontaneous genetic mutations may influence how the brain develops and responds to environmental stressors.
The research increasingly supports a multifactorial model, where genetics, immune activation, folate metabolism, mitochondrial function, oxidative stress, environmental exposures, neurotransmitter balance, gut health, and perinatal factors may interact during sensitive windows of development.
By the end of this post, you’ll understand why autism is complex, why developmental regression should be taken seriously, and how a comprehensive, biology-based approach may help families ask better questions and support the whole child.
Key Takeaways
- Autism spectrum disorder is a complex neurodevelopmental condition influenced by genetics, immune function, environmental exposures, gut health, nutrition, and other biological factors.
- Autism exists on a broad spectrum. Some autistic individuals live independently, while others experience profound disability, medical complexity, and lifelong support needs.
- Developmental regression, including the loss of speech, social engagement, or previously acquired skills, occurs in approximately one-third of children with autism and warrants careful medical evaluation.
- Research suggests that modifiable factors such as nutrition, vitamin D status, environmental exposures, gut health, and personalized medical support may play a role in optimizing health and development.
- A comprehensive medical evaluation may help identify underlying nutritional, metabolic, immune, gastrointestinal, and environmental factors that could be affecting a child’s symptoms, resilience, and quality of life.
Autism Is a Spectrum, But That Word Can Hide Severity
The term “autism spectrum disorder” includes an incredibly wide range of children and adults.
Some individuals are verbal, independent, intellectually gifted, and socially different. Others are profoundly affected, medically complex, non-speaking, unable to toilet independently, prone to elopement or self-injury, or require lifelong, around-the-clock care.
These are not the same clinical realities.
Although they share the same diagnostic label, autism diagnoses can show significant variation in severity, presentation, developmental trajectory, and support needs.
Both groups deserve dignity, respect, and support. But when autism is discussed only through the lens of neurodiversity, we risk overlooking children with profound disability and urgent medical needs.
As autism prevalence rises, profound autism is also increasing. That distinction matters because families living with severe autism need more than acceptance. They need access to medical care, developmental support, environmental evaluation, nutrition support, and clinicians willing to look deeper.
Developmental Regression Should Be Taken Seriously
One of the clearest clinical red flags in autism is developmental regression.
Developmental regression means a child loses previously acquired skills. This may look like loss of speech, reduced eye contact, decreased engagement, fading attention, loss of play skills, or a child who seems to “disconnect” from their environment. Children with autism may also experience challenges with communication, sensory processing, social interaction, repetitive behaviors, sleep, feeding, gastrointestinal health, and emotional regulation.
Studies suggest that developmental regression occurs in roughly one-third of children with autism, often during the toddler years. In our clinical experience, we see nearly 80% of families experience a developmental regression with autism. When this happens, it should not be brushed off as “just a phase.”
Regression may reflect a significant underlying neurobiologic or neuroinflammatory process in a subset of children. That does not mean every case has the same cause, and it does not mean one intervention will apply to every child. But it does mean regression deserves careful medical attention. At Neuronutrition Associates, we view autism as more than a behavioral diagnosis. It is a neurodevelopmental condition with medical, metabolic, immune, gastrointestinal, nutritional, and environmental dimensions that deserve thoughtful evaluation.
The Hopeful Part: There Are Modifiable Factors We Can Support
Families often ask, “What can we do?”
The answer is not simple, and it should never be framed as blame. No parent causes autism by missing a supplement, using antibiotics when needed, being unable to breastfeed, or living in a modern environment.
But there are modifiable factors that may support healthier neurodevelopment, reduce physiologic burden, and help children function better.
Here are several areas where families can take an informed, supportive approach.
Support Breastfeeding When Possible
Breast milk is more than nutrition.
It contains immune factors, microbiome-supportive compounds, and specialized lipids called plasmalogens. Plasmalogens are important components of cell membranes, including those in the brain and nervous system. They may help protect lipid-rich tissues from oxidative stress and inflammation-related damage.
Breastfeeding does not “prevent autism,” and not every family can or should breastfeed. But when possible, breastfeeding may be one early way to support immune development, gut health, microbiome diversity, and cellular membrane integrity.
A 2020 dose-response meta-analysis found that breastfeeding was associated with lower ASD risk, with stronger associations seen with exclusive and longer-duration breastfeeding. This should be interpreted as an association, not proof of causation, but it is one piece of the larger neurodevelopmental support picture.
Use Antibiotics Thoughtfully
Antibiotics can be lifesaving and are sometimes absolutely necessary.
At the same time, the first years of life are a critical window for gut and immune development. Unnecessary antibiotic exposure may disrupt the early microbiome, which is one reason antibiotic stewardship matters in infancy and early childhood.
The practical message is not to avoid antibiotics when they are needed. It is to use them thoughtfully, treat infections appropriately, and support gut recovery after necessary treatment.
Support Vitamin D Status
Vitamin D is not just a bone-health nutrient. It also plays an important role in immune regulation and brain development.
Infants and children may be at greater risk for low vitamin D if they are exclusively breastfed without supplementation, have darker skin tone, limited sun exposure, restrictive diets, malabsorption, or other medical concerns.
Checking risk factors and supplementing appropriately may be one simple way to support immune and neurodevelopmental health. Families should work with their child’s clinician to determine whether vitamin D supplementation or testing is appropriate.
Consider Folate Biology and Personalized Prenatal Nutrition
Emerging research suggests that folate is not one-size-fits-all.
Folate is essential for DNA synthesis, methylation, placental function, and early brain development. But in some women, folate receptor alpha autoantibodies may interfere with folate transport during pregnancy.
A recent pilot randomized study evaluated pregnancies in women who tested positive for folate receptor alpha autoantibodies. In that study, folinic acid supplementation was associated with lower rates of ASD and learning disorders in offspring compared with standard folic acid.
This does not mean folinic acid prevents autism for every child. The study was small and preliminary. But it does suggest that personalized prenatal nutrition, screening, and the right form of folate may matter for some families. This is a key example of where precision medicine may help us move beyond generic recommendations and toward individualized support.
Why a Comprehensive Medical Evaluation Matters for Children With Autism
For children with autism, especially those with regression, irritability, sleep disruption, feeding restriction, gastrointestinal symptoms, immune concerns, or significant developmental challenges, a medical evaluation may provide important insight. If you’re looking for personalized support, you can schedule a visit with our team to discuss your child’s unique health history and needs. A comprehensive evaluation may help identify underlying factors that could be contributing to symptoms, developmental challenges, or difficulty with learning, behavior, sleep, and daily functioning.
Depending on the child, clinicians may consider evaluating areas such as nutrient status, inflammation, mitochondrial function, oxidative stress, methylation, immune activation, gastrointestinal health, environmental toxicant burden, and infection history.
At Neuronutrition Associates, our goal is to understand the child’s physiology and support the systems that may be contributing to symptoms, resilience, and quality of life.
Autism Is Complex. The Care Should Be, Too.
Families do not need fear. They need partnership.
They need clinicians who can acknowledge the rising prevalence of autism without panic. They need a care team that can honor neurodiversity while also recognizing profound disability and medical complexity. They need thoughtful evaluation, early support, and individualized strategies that address the whole child. Many children benefit from individualized therapy, educational support, nutritional interventions, developmental services, and medical care tailored to their unique needs. These supports may help strengthen communication, learning, cognitive development, and overall quality of life.
Autism is not one gene, one exposure, one nutrient, or one event.
It is complex biology.
And when we understand that complexity, we can begin to ask better questions, support children more effectively, and empower families with meaningful tools.
For families who want to learn more about the medical, nutritional, immune, and environmental factors discussed in this article, our Exploring Root Causes of Autism course provides a deeper educational framework.
Looking for More Autism Resources?
Receive research-backed autism education, wellness insights, and updates from Dr. Emily Gutierrez and the Neuronutrition Associates team directly in your inbox.
No spam, just evidence-based education and resources for families. Unsubscribe anytime.
References
- Almsherqi, Z. A. (2021). Potential role of plasmalogens in the modulation of biomembrane morphology. Frontiers in Cell and Developmental Biology, 9, 673917. https://doi.org/10.3389/fcell.2021.673917
- Amnuaylojaroen, T., Parasin, N., & Limsakul, A. (2024). Exploring the association between early-life air pollution exposure and autism spectrum disorder: A systematic review and meta-analysis. Environmental Research, 246, 118111. https://doi.org/10.1016/j.envres.2024.118111
- Duque-Cartagena, T., Álvarez-Mora, M. I., & Flores, R. (2024). Environmental pollutants as risk factors for autism spectrum disorder: A systematic review and meta-analysis of cohort studies. Environmental Research, 258, 119450. https://doi.org/10.1016/j.envres.2024.119450
- Ghozy, S., Tran, L., Naveed, S., Quynh, T. T. H., Helmy, Zayan, A. H., Waqas, A., Hirayama, K., & Huy, N. T. (2020). Association of breastfeeding status with risk of autism spectrum disorder: A systematic review, dose-response analysis and meta-analysis. Asian Journal of Psychiatry, 48, 101916. https://doi.org/10.1016/j.ajp.2019.101916
- Giorlandino, C., Mesoraca, A., Margiotti, K., Fabiani, M., Cupellaro, M., Giorlandino, F., Mastrandrea, M. L., Raffio, R., Pignataro, F., Mangiafico, L., D’Emidio, L., Coco, C., & Milite, V. (2026). Folinic acid supplementation in folate receptor alpha autoantibodies-positive pregnancy: A pilot randomized study on neurodevelopmental outcomes. Reproductive, Female and Child Health, 5, e70053. https://doi.org/10.1002/rfc2.70053
- Horsdal, H. T., Albiñana, C., Zhu, Z., Boelt, S. G., Borbye-Lorenzen, N., Cohen, A. S., Skogstrand, K., Melgaard, L., MacSween, N. J., Thorbek, M. J., Plana-Ripoll, O., Petersen, L. V., Bulik, C. M., Røglum, A. D. B., Mors, O., Nordentoft, M., Werge, T., Moen, G.-H., D’Urso, S., … McGrath, J. J. (2025). Convergent evidence linking neonatal vitamin D status and risk of neurodevelopmental disorders: A Danish case-cohort study. The Lancet Psychiatry, 12(6), 410–420. https://doi.org/10.1016/S2215-0366(25)00099-9
- Lessig, J., & Fuchs, B. (2009). Plasmalogens in biological systems: Their role in oxidative processes in biological membranes, their contribution to pathological processes and aging, and plasmalogen analysis. Current Medicinal Chemistry, 16(16), 2021–2041. https://doi.org/10.2174/092986709788682164
- Łukasik, J., Patro-Gołąb, B., Horvath, A., Baron, R., & Szajewska, H. (2019). Early life exposure to antibiotics and autism spectrum disorders: A systematic review. Journal of Autism and Developmental Disorders, 49(9), 3866–3876. https://doi.org/10.1007/s10803-019-04093-y
- Moukarzel, S., Dyer, R. A., Keller, B. O., Elango, R., & Innis, S. M. (2016). Human milk plasmalogens are highly enriched in long-chain PUFAs. Journal of Nutrition, 146(12), 2412–2417. https://doi.org/10.3945/jn.116.238543
- Shaw, K. A., Williams, S., Patrick, M. E., et al. (2025). Prevalence and early identification of autism spectrum disorder among children aged 4 and 8 years — Autism and Developmental Disabilities Monitoring Network, 16 sites, United States, 2022. MMWR Surveillance Summaries, 74(2), 1–22. https://doi.org/10.15585/mmwr.ss7402a1
- Tan, C., Frewer, V., Cox, G., Williams, K., & Ure, A. (2021). Prevalence and age of onset of regression in children with autism spectrum disorder: A systematic review and meta-analytical update. Autism Research, 14(3), 582–598. https://doi.org/10.1002/aur.2463
